Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is headquartered in Neve Ilan, Israel.
| Revenue (TTM) | $14.52M |
| Gross Profit (TTM) | $-12.33M |
| EBITDA | $-49.51M |
| Operating Margin | -337.00% |
| Return on Equity | -50.10% |
| Return on Assets | -22.30% |
| Revenue/Share (TTM) | $0.22 |
| Book Value | $2.01 |
| Price-to-Book | 0.72 |
| Price-to-Sales (TTM) | 5.95 |
| EV/Revenue | 3.738 |
| EV/EBITDA | -7.41 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 53.10% |
| Shares Outstanding | $69.60M |
| Float | $69.37M |
| % Insiders | 0.35% |
| % Institutions | 27.02% |
Volatility is currently contracting
New York, New York--(Newsfile Corp. - July 9, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Nano-X Imaging Ltd. (NASDAQ: NNOX) and certain of its officers.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nano-X To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nano-X between March 31, 2025 and April 17, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 9, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nano-X Imaging Ltd.
Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the Nano-X Imaging Securities Class Action Where Shares Lost 24.39% Following Disclosure of $17.5 Million Impairment and Manufacturing Restructuring NEW YORK, July 9, 2026 /PRNewswire/ -- IMPORTANT DATE: August 11, 2026. Investors who purchased Nano-X Imaging Ltd.
New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between March 31, 2025 and April 17, 2026, inclusive (the "Class Period"), of the important August 11, 2026 lead plaintiff deadline.
BENSALEM, Pa. , July 08, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Important Notice Regarding Alleged Manufacturing Efficiency Misrepresentations at Nano-X Imaging Ltd. NEW YORK, July 8, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nano-X Imaging Ltd.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nano-X To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nano-X between March 31, 2025 and April 17, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 7, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nano-X Imaging Ltd.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investors of the August 11, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 26-cv-07062, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nano-X securities between March 31, 2025 and April 17, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between March 31, 2025 and April 17, 2026, inclusive (the “Class Period”), of the important August 11, 2026 lead plaintiff deadline.
